Abstract
A polymorphism present in about half the general population can predispose to heart failure as well as enhance responsiveness to β-blockers. The mechanism for this is now being revealed.
Original language | English (US) |
---|---|
Pages (from-to) | 1260-1262 |
Number of pages | 3 |
Journal | Nature medicine |
Volume | 9 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2003 |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)